FullHope Biomedical
Taiwan - New Taipei CityBiotechnology
Focus: FullHope Biomedical is a Taiwan-based biotechnology company founded in 2018 focused on cell-based immunotherapies targeting cancers and autoimmune disorders. The company operates as an early-stage biotech with a single Phase 1 program and minimal disclosed scale.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About FullHope Biomedical
AI assessmentNot HiringNo open roles listed right now. Follow FullHope Biomedical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Dendritic Killer Cell
Colorectal NeoplasmsClinical Trials (1)
NCT02882659Dendritic Killer Cell-based Immunotherapy for Solid Tumors
Phase 1Help build intelligence for FullHope Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.